CD2475/101 40 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD2475/101 40 mg, covering 2020-02-10 to 2020-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris [Phase 2]